# A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis

> **NCT02182167** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Cape Town** · enrollment: 102 (actual)

## Conditions studied

- Drug-Induced Liver Injury

## Interventions

- **DRUG:** IV N-acetylcysteine (NAC)
- **DRUG:** Water

## Key facts

- **NCT ID:** NCT02182167
- **Lead sponsor:** University of Cape Town
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2019-02
- **Final completion:** 2019-02
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2019-02-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02182167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02182167, "A Trial Of Intravenous N-Acetylcysteine In The Management Of Antituberculous Drug-Induced Hepatitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02182167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*